Associate Professor
Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
Portland, Oregon, United States
Dr. Skye Mayo is an Associate Professor of Surgical Oncology, Hepato-Pancreato-Biliary (HPB) surgery, at Oregon Health & Science University (OHSU) and the Knight Cancer Institute in Portland, Oregon. He is board certified in both Complex General Surgical Oncology and in General Surgery having completed a surgical residency at Johns Hopkins and a fellowship at Memorial Sloan Kettering before returning home to Oregon. His clinical practice serves patients with cancers of the liver, bile ducts, gallbladder, and pancreas. He founded and serves as the Director of the Hepatic Arterial Infusion (HAI) Program at the OHSU Knight Cancer Institute and is the Co-Chair of the Clinical Research Review Committee overseeing all clinical trials at thr Knight Cancer Institute. His research focuses on early phase clinical trial development for patients with cancers of the liver and bile ducts, such as metastatic colorectal cancer and intrahepatic cholangiocarcinoma. He is the Principal Investigator for several investigator-initiated trials in HAI as well as the site investigator for several consortium and cooperative group (SWOG) hepatobiliary oncology trials. He has an active basic science collaboration with scientists in the Knight Cancer Institute. Through this collaboration he mentors several residents a year in his research efforts toward the early detection of recurrent cancer and monitoring responses to treatment in patients with colorectal cancer metastatic to the liver, cholangiocarcinoma, and pancreatic cancer.
Saturday, February 17, 2024
7:30 AM - 8:30 AM AST
Saturday, February 17, 2024
7:40 AM - 7:50 AM AST